The QualityStocks Daily Newsletter for Friday, April 9th, 2010 Blog  |  Video  |  Market Basics  |  Quotes & News  |  Clients  |  Partners  |  About Us  |  Contact Us

Today's Top 3 Investment Newsletters


PennyOmega.com (VASO)


Stock Traders Chat (RPC)


Penny Stock Chaser (ETLS)

The QualityStocks Daily

Vasomedical Inc. (VASO)

Today, PennyOmega.com and DrStockPick.com reported on Vasomedical Inc. (VASO), and we are highlighting the Company too, here at the QualityStocks Daily Newsletter.

Vasomedical, Inc. is a leader in EECP® (enhanced external counterpulsation) devices and services for the non-invasive treatment and management of cardiovascular diseases. EECP therapy serves to increase circulation in areas of the heart with less than adequate blood supply. It is currently indicated for use in cases of angina, cardiogenic shock, acute myocardial infarction and congestive heart failure. This therapy also serves to improve systemic vascular function, including improved endothelial cell function. Vasomedical Inc. trades on the OTCBB and the Company's headquarters are in Westbury, New York.

Vasomedical is expanding into the non-invasive diagnostic field by introducing new products such as the Holter monitors. Holter devices monitor and record a patient's cardiac rhythm. Data generated from the Holter monitor undergoes analysis and then finds use in the early detection of cardiac abnormalities such as ischemia.

The Company's core technology, the aforementioned EECP® therapy, provides healthcare professionals that non-invasive therapy for patients suffering from cardiovascular diseases. Vasomedical has a leadership position with the Lumenair™ EECP Therapy System, with over 1,000 systems installed globally.  The Company's growth strategy is their long-term goal of achieving broad-based clinical acceptance of EECP therapy.

In April of last year, Vasomedical, Inc. announced that they received FDA 510k clearance to market Vasomedical-BIOX 1305 ECG Holter Monitor and CB Series Ambulatory ECG Analysis Software. The Vasomedical-BIOX 1305 Holter Monitor is a compact, lightweight, 3-channel ECG Holter monitor designed for monitoring a patient's cardiac rhythm for 24 to 72 hours and recording ECG on a standard SD memory card. This product features a high signal sampling rate and high-resolution digital recording for comprehensive data analysis. This monitor has already received CE Marking certification to market in the European Union countries.

Data recorded by the Model 1305 can be quickly analyzed using the proprietary Vasomedical-BIOX CB Series Analysis Software. The CB series software provides clear, quick, and accurate recognition of QRS complexes and classification. The CB series software also provides a proprietary two-tier automatic classification process for "suspicious" waveforms, as well as comprehensive event reports and ST-segment reports. In addition, the software has many other data viewing, analysis, and reporting capabilities.

Today, Vasomedical, Inc. announced the receipt of the US FDA 510(k) clearance on April 2, 2010 to market their Vasomedical-BIOX™ Model 2301 Combined ECG Holter and Ambulatory Blood Pressure Monitoring Recorder and Software Analysis System.

"These are the first in a line of Vasomedical-BIOX™ ECG Holter and Ambulatory Blood Pressure Monitoring Systems that Vasomedical intends to bring to the marketplace," said Dr. Jun Ma, President and CEO. He further stated that "the introduction of Model 1305 Holter Monitor last year placed Vasomedical into the patient monitoring business with a high quality digital equipment that has enjoyed international success. The Model 2301, however, will make Vasomedical a supplier of ambulatory equipment, because it is so far the only combined ambulatory ECG/blood pressure recording device in the United States."

Vasomedical Inc. (VASO) closed Friday's trading session at $0.31 up 342.86 percent. Volume was 8,805,237.

Tech/Ops Sevcon Inc. (TO)

Today we are highlighting Tech/Ops Sevcon Inc. (TO), here at the QualityStocks Daily Newsletter.

Tech/Ops Sevcon, Inc. is a global leader in the design, manufacture and marketing of microprocessor-based controls. These controls are for zero emission electric vehicles. The Company supplies customers around the world from their operations in the United Kingdom, the USA, France, and the Far East, and through an international dealer network. Tech/Ops Sevcon Inc. trades on the NASDAQ Capital Market. The Company has their U.S. base in Southborough, Massachusetts.

The Company's microprocessor-based controls are for varying the speed and movement of vehicles, to integrate specialized functions, and to optimize the energy consumption of the vehicles' power source. Tech/Ops Sevcon's customers are manufacturers of on and off road vehicles. These vehicles include cars, trucks, buses, motorcycles, forklift trucks, aerial lifts, mining vehicles, airport tractors, sweepers, and other electrically powered vehicles. The Company also provides metalized film capacitors for use in the power electronics, signaling, and audio equipment markets.

In January of this year, Tech/Ops Sevcon, Inc. reported net income of $159,000, or $.05 per share, for the first quarter ended January 2, 2010, compared with a net loss of $.04 per share last year. Improved sales of new Gen4 AC vehicle control products along with the results of effective cost and cash management enabled the Company to record their first quarterly profit since the beginning of the severe economic decline in their global markets that began in the fall of 2008.

On February 24, 2010, Tech/Ops Sevcon, Inc. announced that, at a meeting on February 17th, 2010, the Board of Directors voted to elect Fred Wang a Director, with a term expiring at the Annual Meeting of Stockholders in 2012.

Mr. Wang has more than 35 years experience in high tech development companies. These include, as Head of R&D, product marketing and sales and service operations at Wang Laboratories, Inc. Mr. Wang is a Director and Trustee of the Wang Foundation. Mr. Wang has a B.Sc. in Applied Mathematics from Brown University and a Masters Degree in Public Administration from the John F. Kennedy School of Government, Harvard University.

Tech/Ops Sevcon Inc. (TO), closed Friday's trading session at $5.20 up 0.44 percent. Volume was 2,200.

Overstock.com Inc. (OSTK)

Recently, Investorplace.com and Trading Markets reported on Overstock.com Inc. (OSTK), MicroCap Press and Forbes did earlier, and we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Headquartered in Salt Lake City, Utah, Overstock.com Inc. is an online retailer offering closeout and discount brand, and non-brand name merchandise in the United States. The Company began in 1999 when Dr. Patrick Byrne had an idea and saw the need for using the Internet to liquidate excess inventory. Overstock.com came into being to allow customers the opportunity to buy from the comfort of their homes without having to fight mall stores and parking lot congestion. Trading on the NASDAQ Global Market, Overstock.com Inc. went public on May 30, 2002.

The Company's focus is providing quality brand-name merchandise at deep discounts. They have partnerships with many fine brand-name companies so they can offer their customers great selection. They have an inventory of over 63,000 non-BMMG (Books, Music, Movies, and Interactive Games) products along with more than 720,000 BMMG products. Overstock calculates that, since launching their site in October of 1999, Overstock.com has saved consumers millions of dollars off the retail prices recommended by manufacturers.

Their product selection includes bed-and-bath goods, home decor, kitchenware, jewelry, electronics and computers, sporting goods, apparel, and designer accessories. Overstock.com also markets books and magazines, CDs, DVDs, videocassettes, and video games. They also have an online auction service, which is their online marketplace for buying and selling goods and services. Users of this portal can also list cars and real estate for sale there.

On March 31, 2010, Overstock.com Inc. announced that the Company turned a profit in the fourth quarter as revenue grew 27 percent. They reported net income of $12.7 million, or 55 cents per share, compared with a loss of $$705,000, or 3 cents per share a year ago. Revenue grew to $322.4 million from $253.8 million a year ago. For the year, they posted a profit of $7.7 million, or 33 cents per share, compared with a loss of $11 million, or 48 cents a share, a year ago. Chief Executive Mr. Patrick Byrne said it's the Company's first annual profit in twelve years of business.

Overstock.com Inc. (OSTK) closed Friday's trading at $20.11, which was up 1.67 percent. Their volume today was 292,200.

Immunosyn Corporation (IMYN)

OTC Picks reported earlier on Immunosyn Corporation (IMYN), and we choose to highlight the Company today, here at the QualityStocks Daily Newsletter.

Immunosyn Corporation holds a license to market, distribute, and sell a biopharmaceutical drug product, SF-1019, as well as variants of SF-1019 for multiple uses globally. The Company is a development stage marketing and distribution company. Founded in 2006, they have their corporate headquarters in San Diego, California. Trading on the OTC Bulletin Board, Immunosyn Corporation is a subsidiary of Argyll Biotechnologies, LLC. Immunosyn is part of the Biotechnology industry in the Healthcare sector.

The use of SF-1019 would be for the treatment of various diseases and pathological conditions. These primarily include chronic inflammatory demyelinating polyneuropathy, diabetic neuropathy, and diabetic ulcers. SF-1019 will be marketable upon receipt of potential regulatory approval in the appropriate jurisdictions.

Immunosyn Corporation plans to build a sales and marketing force, and related resources to sell SF-1019, if approved for human use under their agreement with Argyll Biotechnologies, LLC. Immunosyn also plans to improve awareness and acceptance of SF-1019 in the medical community.

The development of SF-1019 was from extensive research into Biological Response Modifiers (BRMs) undertaken at Mississippi State University; St George's, University of London (formerly St George's Hospital Medical School); Ohio University; and Methodist Hospital. 

SF-1019 is the current name of the platform technology of Argyll Biotechnologies, LLC.  The belief is that SF-1019 is one of a new class of therapeutics made from mammalian cells.  As an isolated compound, SF-1019 is comprised of low molecular weight lipo-peptides.

Pre-clinical human studies and clinical trials in animals have shown SF-1019 to provide therapeutic benefits without toxic or pyrogenic (fever-causing) effects at therapeutically effective dosages.  A major benefit of SF-1019 is its perceived ability to simultaneously target, activate and support the modulation of both the innate and adaptive immune systems, having a significant effect on many neurological and demyelinating conditions.

Research suggests the current product has additional developmental potential. This is because it also possesses analgesic properties with an ability to reduce substantially the inflammation attending a number of clinical conditions. These include Multiple Sclerosis (MS), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Reflex Sympathetic Dystrophy Syndrome, (RSD or RSDS) and other autoimmune and neurological disorders.

Today, Immunosyn Corporation (IMYN) closed at $0.55 up 12.24 percent. Volume was 200,840.

ImmunoCellular Therapeutics, Ltd. (IMUC)

This week, Cool Penny Stocks, HotOTC.com, Stock Rich, and Ceocast News reported on ImmunoCellular Therapeutics, Ltd. (IMUC), SmallCap Voice did earlier, and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Headquartered in Los Angeles, California, ImmunoCellular Therapeutics, Ltd. is a clinical-stage company that trades on the OTCBB. They are developing immune-based therapies for the treatment of brain and other cancers. The Company recently completed a Phase I trial of their lead product candidate, ICT-107. This is a dendritic cell-based vaccine targeting multiple tumor-associated antigens for glioblastoma. They are planning to begin a multicenter phase II study in the second half of 2010.

ImmunoCellular Therapeutics' "off the shelf" therapeutic vaccine product candidate (ICT-121) targeting cancer stem cells for multiple cancer indications is targeted by the Company to enter clinical trials for glioblastoma during the second half of 2010. The Company entered into an agreement with Formatech, Inc. for the manufacture and development of ICT-121, for an upcoming clinical trial. The agreement calls for Formatech to develop a formulation for ICT-121 that allows for long-term stability of the vaccine as well as suitability for intradermal injection.

ImmunoCellular Therapeutics is in pre-clinical development of a monoclonal antibody product candidate for the treatment of small cell lung cancer and pancreatic cancer. They are also evaluating their platform technology for monoclonal antibody discovery to target cancer stem cells.

ImmunoCellular Therapeutics, Ltd. entered into a research and license option deal with the Roche Group for one of the Company’s monoclonal antibody product candidates for the diagnosis and treatment of ovarian cancer and multiple myeloma. This research and license option deal provides for potential licensing and milestone payments of $32MM and royalties. This is if the Roche Group exercises their option and commercializes this antibody technology for multiple indications.

Last month, ImmunoCellular Therapeutics, Ltd. announced that they received a Notice of Allowance from the United States Patent and Trademark Office. It covers technology relating to monoclonal antibodies that bind to certain epitopes present on pancreatic cancers. This patent will broaden their proprietary intellectual property for ICT-109 and ICT-37, two of their monoclonal antibody product candidates.

ImmunoCellular Therapeutics, Ltd. (IMUC) closed Friday's trading session at $1.38 up 7.81 percent. Volume was 518,132.

Digital Ally Inc. (DGLY)

Today we are highlighting Digital Ally Inc. (DGLY), here at the QualityStocks Daily Newsletter.

Digital Ally, Inc. develops, manufactures and markets advanced technology products for law enforcement, homeland security and commercial security applications. The Company's primary focus is digital video imaging and storage. Digital Ally Inc. trades on the NASDAQ Capital Market. The Company has their headquarters in Overland Park, Kansas.

Digital Ally's main concentration is in the development and application of new concepts. However, the Company also recognizes the value of retrofitting existing installations with cost-effective digital sub-systems. This flexibility allows them to compete in established markets as they simultaneously promote the industry's transition towards advanced technologies. The Company's experience and expertise in integrating electronic, radio, and computer, mechanical and multi-media technologies gives them the means to create unique solutions.

Digital Ally's digital audio/video recording and storage product line consists of an in-car digital audio/video system that is integrated into a rear view mirror, and an all-weather mobile digital audio/video system designed for motorcycle, ATV, and boat uses. Their line up also consists of a miniature body-worn digital audio/video camera, and a digital audio/video system, which is integrated into a law-enforcement style flashlight.

An example of the Company's product line is their Digital In-Car Video System Police Cameras. It uses the latest generation of technology that is so small and advanced that the entire Digital Video System is integrated into a replacement rear view mirror. A user removes the factory rear view mirror and installs the Digital Ally DVM system. The video monitor is behind a high quality "one-way" mirror. In this way, when it is not in use, it's invisible. The unique design of the police camera system allows for easy installation in any make or model of vehicle. It doesn't take up extra space and doesn't interfere with any other equipment in a car.

On March 22, 2010, Digital Ally, Inc. announced their operating results for the quarter and year ended December 31, 2009. For the three months ended December 31, 2009, Digital Ally reported record revenue of approximately $9.2 million, which represented a 38 percent increase compared to revenue of approximately $6.7 million in the fourth quarter of 2008. For the twelve months ended December 31, 2009, the Company reported revenue of approximately $26.4 million, compared with revenue of approximately $32.6 million in the previous year.

Digital Ally Inc. (DGLY) closed Friday's trading at $1.79 up 1.02 percent. Volume was 39,029.

Deer Consumer Products, Inc. (DEER)

The Online Investor, Trading Markets, and Greenbackers reported earlier on Deer Consumer Products, Inc. (DEER), and we highlight the Company today, here at the QualityStocks Daily Newsletter.

Trading on the NASDAQ Global Market, Deer Consumer Products, Inc. is a leading designer, ODM/OEM manufacturer and global marketer of quality small home and kitchen electric appliances. The Company's support is their more than 103 patents, trademarks, copyrights and approximately 2,000 company-trained seasonal and full-time staff. Deer Consumer Products, Inc. has their corporate headquarters in ShenZhen, China.

The Company's product lines include blenders, juicers, soymilk makers and a broad spectrum of other home appliances designed to make today's lifestyles simpler and healthier. Deer Consumer Products has more than 100 global clients/branded products. These include Black & Decker, Ariete, Disney, Toastmaster, Magic Bullet, Back to Basics and Wal-Mart. They also have a rapidly expanding China domestic market footprint.

Last month, Deer Consumer Products Inc. said that their 2009 profit almost tripled. Yearly profit nearly tripled to $12.4 million, or 53 cents per share, from $4.4 million, or 20 cents per share last year. Revenue rose 86 percent to $81.3 million. In addition, the Company announced last month that "Deer" branded juicer and blender products are the best selling products in their categories at China's largest online shopping mall, Taobao.com.

On March 22, 2010, Deer Consumer Products, Inc. announced that the Company launched a high end, automatic espresso-machine product line. They also announced that they started shipments to the European markets. Deer announced their satisfaction on having passed stringent quality testing standards for the EU markets under this top global brand name, which dominates the espresso machine market in Europe. They intend to launch a similar product line in select premium segments of the Chinese domestic markets in 2010.

Deer's customer base consists primarily of large appliance companies, distributors and home supply chains. The Company's top ten customers account for over 50 percent of their annual sales.

In addition to designing and manufacturing products under their own brands, Deer also designs and manufactures products for many of the world's largest appliance manufacturers. Some of these customers include Focus Electric, Home Depot, Sattar and Girmi.

Deer Consumer Products, Inc. (DEER) closed Friday's session at $11.53 down 1.62 percent. Volume was 341,763.

China Pediatric Pharmaceuticals, Inc. (CPDU)

Today we choose to highlight China Pediatric Pharmaceuticals, Inc. (CPDU), here at the QualityStocks Daily Newsletter.

China Pediatric Pharmaceuticals, Inc. identifies, discovers, develops manufactures and distributes both prescription and over-the counter, pharmaceutical products. This includes both conventional and Traditional Chinese Medicines (TCMs). These pharmaceutical products are for the treatment of some of the most common ailments and diseases. The Company has pediatric medicine as their focus.

China Pediatric Pharmaceuticals, Inc.'s manufacturing facility is in Baoji City, Shaanxi Province. The Company has their corporate headquarters in Xi’an, Shaanxi Province, China. They currently trade on the OTC Bulletin Board.

The Company distributes their high value, branded medicines, both prescription and OTC, through exclusive territory agents. These agents sell the Company's products directly to local pharmacies who in turn sell them to their retail customers.

On January 19, 2010, China Pediatric Pharmaceuticals, Inc. announced that the Company applied for listing approval on the NASDAQ Capital Market. The application is subject to review by NASDAQ's Listing Qualifications Department. This is for compliance with all NASDAQ Capital Market requirements. China Pediatric Pharmaceuticals, Inc.'s common stock will continue to trade on the OTC Bulletin Board under their current symbol, CPDU, until the Company is notified of their acceptance.

On January 19, 2010, Mr. Jun Xia, Chairman and Chief Executive Officer of China Pediatric Pharmaceuticals, Inc. said, "This is an important milestone for China Pediatric Pharmaceuticals, and we are committed to working with NASDAQ to fulfill all of its listing requirements. As a senior exchange NASDAQ is well suited for high-growth companies such as China Pediatric Pharmaceuticals that meet its stringent listing requirements. With a NASDAQ listing, our visibility will increase among investors who follow companies like ours, improving trading volume and liquidity. This should, in turn, attract new investors to our Company."

In February of this year, China Pediatric Pharmaceuticals, Inc. reported that they closed a private placement financing. They issued 375,000 shares of the Company's common stock at a price of $4.00 per share for an aggregate purchase price of $1.5 million. They plan to use the proceeds of the Regulation S private placement for general corporate purposes such as working capital.

China Pediatric Pharmaceuticals, Inc. (CPDU) closed Friday's trading session at $3.00 up 57.89 percent. Volume was 9,423.

The QualityStocks Company Corner

eDOORWAYS Corporation (EDWY)

The QualityStocks Daily Newsletter would like to spotlight eDOORWAYS Corporation (EDWY) Today eDoorways Corporation closed trading at $0.0111, which was down 3.48 percent. Their volume today was 3,767,006 shares.

The eDOORWAYS Corp.'s (EDWY) same day release of the Facebook  integration model, offline notification through Twitter, and post of the written address to shareholders had both shareholders and non-shareholders alike keenly interested in today's shareholder conference call.

eDOORWAYS Corp. (EDWY) is committed to solving lifestyle problems for consumers while driving traffic to suppliers and service providers who offer innovative merchandise and solutions. The company has the potential to completely change the future landscape of business by offering a unique and comprehensive service that saves consumers valuable time and money. By uniting a consumer with the larger global consumer community, retailers, and manufacturers in an effective new way, eDOORWAYS promotes “dynamic” commerce, as opposed to the static model currently in existence.

The Company plans to capitalize on several emerging new trends. These newly created opportunities include: the large success of Web 2.0 Internet community service offerings such as MySpace, the movement towards niche marketing and targeted advertising, the introduction of new technologies that enable instantaneous, online presentation of information, and the rising consumer preference for using the Internet to gain information before making purchasing decisions.

eDOORWAYS plans to introduce local services using a city-by-city strategy that will minimize capital requirements, reduce staffing requirements, and optimize generated revenues. Ten major cities are targeted for launch in the first year. Advertising, PR campaigns and viral word-of-mouth will be used to give a public presentation to experts as well as educate the market.

The key benefits offered to consumers include a higher level of engagement with vendors, trusted information from other consumers, and superior customer service. Revenues will be generated through advertising placement fees, premium services, preferential placement fees, and a percentage of sales transactions. eDOORWAYS' progressive vision and professional management team makes it an attractive investment opportunity. Disclaimer

eDOORWAYS Corporation Blog

eDOORWAYS Corporation News:

eDoorways Shareholder Conference Call Expected to Be a Success -- Off Heels of Additional Platform Developments and Written Address

eDoorways Announces Its Release of 'Facebook Connect' With a Twitter Twist

eDoorways Announces Dates for Shareholder Conference Call and Written Shareholder Address

General Environmental Management Inc. (GEVI)

The QualityStocks Daily Newsletter would like to spotlight General Environmental Management Inc. (GEVI) Today, General Environmental Management Inc. closed trading at $0.19, which was up 58.33 percent. Their volume today was 22,250 shares.

General Environmental Management Inc. (GEVI) is in the process of shifting its business focus from hazardous waste field services to the fast growing water treatment and waste-to-energy markets. Since its inception in 2002, the Company has grown at a compounded annual rate of 48% to generate annual revenues of $37M from only $2.3M.

This strategic decision was made after an all inclusive analysis of GEVI's opportunity in the environmental management business. Although the company could work through the current economic downturn and build revenue in its field services business, they believe that shareholders will be rewarded by moving the company into the higher margin, faster growing business segments.

Within the U.S. alone, the water industry is a $120 Billion market that is expected to grow at 6-7% over the next year. On a global basis, the industry size exceeds $400 billion annually and increasing with the demands of a growing world population. The global waste-to-energy market, on the other hand, is a $19.9 billion market with expected CAGR of 6.7% over the next five years.

In order to ensure every advantageous acquisition opportunity is properly evaluated, GEVI has retained the services of General Pacific Partners (GPP). With a very selective and calculated acquisition strategy in place, GEVI is poised for continued success. Disclaimer

General Environmental Management Inc. Blog

General Environmental Management Inc. News:

General Environmental Management Completes Sale of Western Region Field Service Business and Rancho Cordova TSDF to Luntz Acquisition LLC

General Environmental Management Announces Results of Special Meeting of Stockholders

General Environmental Management Announces Upcoming Proxy Vote for Sale of Waste Management Business

National Automation Services, Inc. (NASV) 

The QualityStocks Daily Newsletter would like to spotlight National Automation Services, Inc. (NASV). Today National Automation Services, Inc. closed trading at $0.13, which was up 8.33 percent. Their volume today was 79,350 shares.  

National Automation Services, Inc. (NASV) is a public holding company focused on designing, engineering, installing and maintaining automated control systems for such business applications as waste water treatment, water treatment, airport security, bottling plants, power plants, metals, mining, breweries, food processing, tire making, textiles, plastics and nearly all production activities.  

Dominant players in the $500 Billion national and international automation controls market include Siemens, Honeywell, Fisher Controls, Johnson Controls and others. In addition to the multi-nationals, it has been estimated that there could be as many as 300 local and regional firms providing automation control services. In general, these companies have an edge on the larger behemoths because they can better respond to the needs of local business and municipalities.  

Unfortunately, for these smaller companies, they compete in a limited market space, have stunted growth prospects and have no way of monetizing their asset value. NAS aims to capitalize on this condition by acquiring and integrating the strongest local and regional players into a new organization that would allow for the synergies and efficiencies of a national company while keeping the competitive advantages of decentralized management and service.  

Of the 300 local and regional automation companies, 42 meet the company’s acquisition criteria; 11 of which have been targeted for acquisition over the next two years. NAS projects year-end 2010 revenues of more than $47 Million and year-end 2011 revenues of over $140 Million predicated on meeting its targeted acquisition schedule. With a solid business plan in place, NAS has a firm foundation to generate strong cash flow and increase shareholder value over the long-term. Disclaimer

National Automotion Services, Inc. Blog

National Automation Services, Inc. News:

National Automation Services, Inc. Secures Equity Financing Commitment for $5 Million

National Automation Services, Inc. Announces an Update on $440,000.00 Contract Award With General Contractors to the City of Glendale for the Oasis Water Campus Central Control Station Project

National Automation Services, Inc. Announces an Update on $440,000.00 Contract Award With General Contractors to the City of Glendale for the Oasis Water Campus Central Control Station Project

Newport Digital Technologies, Inc. (NPDT)

The QualityStocks Daily Newsletter would like to spotlight Newport Digital Technologies, Inc. (NPDT).  Today, Newport Digital Technologies, Inc. closed trading at $0.0170, which was up 6.25 percent. Their volume today was 479,869 shares.

Newport Digital Technologies, Inc. (NPDT) offers a rich portfolio of competencies in RFID (Radio-Frequency Identification), WiMAX, eLearning, LED Signage, and Security & Surveillance. Utilizing its technological expertise and creativity, the company enables its customers to take full advantage of the nearly limitless possibilities offered by increasingly sophisticated applications.

Newport is committed to meeting specific customer requirements by delivering complete solutions for a broad spectrum of applications. The company is building a global distribution, licensing, and sales network of industry-leading partners as well as third-party Original Design Manufacturers (ODMs) and component suppliers to ensure its clients world-leading technology with strong local support capabilities.

The company has established a synergistic partnership with Taiwan’s premier technology incubators, the Institute for Information Industry (III) and the Industrial Technology Research Institute (ITRI), under which the company develops and customizes their advanced technologies to meet the needs of businesses across the globe. Having a pool of more than 7,900 engineers and scientists, these R&D powerhouses have developed cutting edge capabilities in fields such as Information Communications Technology (ICT), electronics, and nanotechnology.

Newport’s management team has accumulated a wealth of knowledge and experience within the technology industry as well as the corporate world. Maintaining a strong track record of delivering results to investors and customers, the team retains over two centuries of combined experience. Leveraging each team member’s area of expertise, Newport has established a solid foundation to penetrate emerging technology markets.Disclaimer

Newport Digital Technologies, Inc. Blog

Newport Digital Technologies, Inc. News:

Newport Digital Technologies, Inc. to Exhibit at InfoComm 2010 - June 5th - 11th at the Las Vegas Convention Center in Las Vegas, Nevada

Newport Digital Technologies, Inc. Announces the Appointment of Steve Ruey-Long Chen, Former Minister of the Ministry of Economic Affairs of Taiwan, to the Advisory Board

Newport Digital Technologies, Inc. to Exhibit at RFID Journal Live! 2010 - April 14-16, at the Orange County Convention Center, in Orlando, Fla.

BakBone Software (BKBO) Names Steve Martin Interim CEO and Expects Fourth Quarter Booking to be Within Guidance

Universal Data Management provides a data-centric approach to integrating data protection and improving corporate compliance that allows companies to take the next step towards prominence. Today, BakBone took a step towards enhancing its future by naming an Interim CEO and announcing its fourth quarter bookings.

Taking over as BakBone’s Interim CEO is Steve Martin who is the young company’s current CFO. Martin joined BakBone in August of 2008 and has evolved into a respected leader in the industry. Martin replaces James R. Johnson who ceases to be BakBone’s President and CEO after submitting his resignation.

In addition to naming Martin their Interim CEO, BakBone reported that bookings for the fiscal fourth quarter, which ended on March 31 of this year, are currently expected to be $14.1 million. This will enable BakBone to achieve full fiscal year bookings within the lower end of guidance of $56.5 million to $5.5 million.

BakBone intends to report fiscal fourth quarter and full year results in early June and has approximately $4.8 million in cash and $10.7 in receivables as of March 31, 2010.

When asked his thoughts on his new position and the future of BakBone, Interim CEO and CFO Steve Martin was quoted as saying, “We thank Jim for his contributions to BakBone over the past six years and wish him well in his future endeavors. Our focus over the next few weeks will be in getting fiscal 2011 off to a successful start, increasing our efficiencies and productivity, and maximizing the market opportunities available to our many product lines. Our team remains excited about the potential for our company in the marketplace as well as executing to that potential.”

MMR Information Systems (MMRF) Signs With Chartis to Offer Electronic Personal Health Records Worldwide

MMR Information Systems has been chosen by Chartis Inc., a global property-casualty and general insurance organization serving more than 40 million clients worldwide, to power a system allowing policyholders and their families to access, store, and manage their electronic personal health records and other important documents.

Through a strategic alliance with MMR, Chartis will initially offer health records to accident and health policyholders, but is expected to expand the offering to additional product lines in the coming months. The system will be based upon MMR’s MyMedicalRecordsTM technology, and allows records (initially available in 7 different languages) to be accessed and stored in a secure, encrypted, Web-based application, which users can tap 24/7 from anywhere in the world. In addition, the system will include a virtual MyESafe deposit box, for the storage of passports, deeds, wills, and other important documents.

The system will incorporate a sophisticated file management system, as well as a separate emergency log-in feature allowing first responders and other medical personnel to obtain potentially life-saving information, such as blood type, medications, and critical allergies.

MMR Chairman and CEO, Robert H. Lorsch, said, “It is especially exciting to work with Chartis to introduce this life-saving service at a time when the world is spending hundreds of billions of dollars on health information technologies.” The President of Chartis International Consumer Lines, Jeffrey kestenbaum, added, “Chartis is excited to be able to offer its clients the ability to manage their personal health records and other critical personal documents, and make them available around the clock and from anywhere in the world”.

MMR Information Systems, through MyMedicalRecords, Inc., the company’s wholly-owned operating subsidiary, provides secure and easy-to-use online personal health records and electronic safe deposit box storage solutions, allowing individuals and families to maintain and access all their medical records and other important documents from anywhere in the world using the internet.

Inovio Biomedical Corp. (INO) Awarded Grant for Hepatitis C Virus DNA Vaccine Research

Inovio Biomedical Corp. is focused on the design, development and delivery of a new generation of vaccines, called DNA vaccines, to prevent and treat cancers and infectious diseases. The company’s SynCon technology enables the design of universal vaccines capable of protecting against multiple strains of pathogens such as influenza.

The company announced that it and its team of brilliant researchers and collaborators from Drexel University, Cheyney University and the University of Pennsylvania have received a $2.8 million grant from the Pennsylvania Department of Health to develop a DNA vaccine to treat hepatitis C virus (HCV). The grant will fund pre-clinical studies to test the safety and effect on the immune system of Inovio’s novel vaccines.

Inovio’s vaccines were designed to treat persons who are chronically infected with hepatitis C virus and have not responded to currently available therapies. Persons with chronic HCV infection face an increased risk of developing hepatocellular cancer, a difficult-to-treat cancer with a poor prognosis. HCV is a major global health problem with over 170 million people infected worldwide.

The funds for the grant came from Pennsylvania’s share of the nationwide settlement with the tobacco companies. Pennsylvania Secretary of Health, Everette James, said that this “confirms Pennsylvania’s commitment to use tobacco settlement dollars to improve the health of its citizens.” These competitive grants focus on specific research priorities established by the Health Research Advisory Committee. These grants are awarded as part of the Commonwealth Universal Research Enhancement Program (CURE) which supports clinical, health services and biomedical research.

ITEX Corporation (ITEX) to Provide PC Upgrades for Their Franchise Network and Corporate Offices

ITEX Corporation announced that they would provide new computers, software and monitors for its franchise network and corporate offices to replace existing desktop systems. The software provided will include Microsoft Windows 7 and Office Small Business 2010. Upon the launch of Office 2010, ITEX Corporation expects to purchase 180 Dell computer systems.

Steven White, ITEX Chairman and CEO stated, “Our continued success is due in part to our organization utilizing leading technology products and services. We are committed to providing our franchisees and corporate staff with the finest tools to be as productive and efficient as possible. Our PC infrastructure was standardized on Dell™ products and Microsoft™ software in late 2004 and we are timing our network-wide PC upgrade with the launch of Office 2010.”

Headquartered in Bellevue, Washington, ITEX Corporation helps businesses generate new sales, conserve cash flow and increase profits. ITEX, The Membership Trading Community(SM), is a network of participating member businesses. The Membership Trading Community(SM) is a marketplace for B2B cashless transactions across North America.

ITEX has their payment technology platform for processing cashless business transactions. They also have an exclusive distribution channel. Member businesses use the Company’s digital currency “ITEX dollars” to exchange goods and services instead of using cash. ITEX processes more than $100 million a year in Gross Merchandise Value (GMV) across 24,000 member businesses and 90-plus franchisees and licensees.

Through ITEX, an enterprise can sell their products and services to a growing network of ITEX Members. They also have access to experienced local Trade Directors that facilitate transactions. The powering of ITEX is through ITEX Payment Systems. This is the leading payment technology platform for processing cashless business transactions.


Sponsors of the Day


The QualityStocks Public Company Sponsor News

Micro Identification Technologies Inc. (MIT) (MMTC) to be Featured in Small Cap Stock Newsletter QualityStocks Daily



About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

Home | Blog | Video | Market Basics | Media | Partners | Clients | About Us | Contact Us | Disclaimer | Unsubscribe
Copyright 2006-2009 QualityStocks 3370 N. Hayden Rd. Suite 123-591 Scottsdale, AZ 85251 480-374-1336